Monthly Archives: December 2019

CLASS ACTION UPDATE for UA, AFI and ACB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / December 9, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Under Armour, Inc. (NYSE:UA)

UA Lawsuit on behalf of: investors who purchased August 3, 2016 – November 1, 2019
Lead Plaintiff Deadline : January 6, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/under-armour-inc-loss-form?prid=4795&wire=1

According to the filed complaint, during the class period, Under Armour, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Under Armour shifted sales from quarter to quarter to appear healthier, including to keep pace with their long-running year-over-year 20% net revenue growth; (2) undisclosed to the investing public, the Company had been under investigation by and cooperating with the U.S. Department of Justice and U.S. Securities and Exchange Commission since at least July 2017; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Armstrong Flooring, Inc. (NYSE:AFI)

AFI Lawsuit on behalf of: investors who purchased March 6, 2018 – November 4, 2019
Lead Plaintiff Deadline : January 14, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/armstrong-flooring-inc-loss-form?prid=4795&wire=1

According to the filed complaint, during the class period, Armstrong Flooring, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had engaged in channel stuffing to artificially boost sales; (2) the Company's internal control over inventory levels was not effective; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis

Aurora Cannabis Inc. (NYSE:ACB)

ACB Lawsuit on behalf of: investors who purchased September 11, 2019 – November 14, 2019
Lead Plaintiff Deadline : January 21, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/aurora-cannabis-inc-loss-form?prid=4795&wire=1

According to the filed complaint, during the class period, Aurora Cannabis Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) as opposed to the Company's representations, Aurora's revenue would decline in its first quarter of fiscal 2020 ended September 30, 2019; (2) the Company would halt construction on its Aurora Nordic 2 and Aurora Sun facilities; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 569704

CLASS ACTION UPDATE for QUAD, REZI and CGC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / December 9, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Quad/Graphics, Inc. (NYSE:QUAD)

QUAD Lawsuit on behalf of: investors who purchased February 21, 2018 – October 29, 2019
Lead Plaintiff Deadline : January 6, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/quad-graphics-inc-loss-form?prid=4794&wire=1

According to the filed complaint, during the class period, Quad/Graphics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's book business in United States was underperforming; (2) as a result, the Company was likely to divest its book business; (3) the Company was unreasonably vulnerable to decreases in market prices; (4) to remain financially flexible while market prices decreased, the Company was likely to cut its quarterly dividend and expand its cost reduction programs; and (5) as a result of the foregoing, positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Resideo Technologies, Inc. (NYSE:REZI)

REZI Lawsuit on behalf of: investors who purchased October 29, 2018 – October 22, 2019
Lead Plaintiff Deadline : January 7, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/resideo-technologies-inc-loss-form?prid=4794&wire=1

According to the filed complaint, during the class period, Resideo Technologies, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) the negative operational effects of the Company's spin-off from Honeywell International Inc. were more substantial and persistent than disclosed and had negatively affected Resideo's product sales, supply chain, and gross margins, putting the Company's FY19 financial forecasts at risk; and (b) as a result of the foregoing, the Company's financial guidance lacked a reasonable basis and the Company was not on track to make its FY19 guidance as claimed.

Canopy Growth Corporation (NYSE:CGC)

CGC Lawsuit on behalf of: investors who purchased June 21, 2019 – November 13, 2019
Lead Plaintiff Deadline : January 20, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/canopy-growth-corporation-loss-form?prid=4794&wire=1

According to the filed complaint, during the class period, Canopy Growth Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing weak demand for its softgel and oil products; (2) as a result, the Company would be forced to take a CA$32.7 million restructuring charge due to poor sales, excessive returns, and excess inventory; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 569703

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SEE, AZZ and MMSI

NEW YORK, NY / ACCESSWIRE / December 9, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Sealed Air Corporation (NYSE:SEE)

Investors Affected : November 5, 2014 – August 6, 2018

A class action has commenced on behalf of certain shareholders in Sealed Air Corporation. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) Sealed Air had hired its auditor, E&Y, pursuant to a conflicted and improper process and in order to help facilitate defendants' efforts to engage in accounting fraud; (b) Sealed Air's deduction of $1.49 billion in connection with the Settlement was indefensible and done for the improper purpose of artificially inflating the Company's financial results; (c) Sealed Air had artificially inflated its earnings, cash flows, and operating income during the Class Period; (d) as a result of the above, Sealed Air's Class Period financial statements were materially false and misleading and not prepared in conformance with GAAP; and (e) as a result of the above, Sealed Air's statements regarding its financial results, business, and prospects were materially misleading.

Shareholders may find more information at https://securitiesclasslaw.com/securities/sealed-air-corporation-loss-submission-form/?id=4793&from=1

Azz, Inc. (NYSE:AZZ)

Investors Affected : July 3, 2018 – October 8, 2019

A class action has commenced on behalf of certain shareholders in Azz, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's internal controls over financial reporting were not effective; (2) the Company improperly implemented ASC 606 which resulted in improper revenue reconciliations; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/azz-inc-loss-submission-form/?id=4793&from=1

Merit Medical Systems, Inc. (NASDAQ:MMSI)

Investors Affected : February 26, 2019 – October 30, 2019

A class action has commenced on behalf of certain shareholders in Merit Medical Systems, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the integrations of acquired companies Cianna Medical, Inc. and Vascular Insights, LLC, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (b) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during FY19; and (c) in light of the foregoing, the Company's reported financial guidance for FY19 and FY20 was made without a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/merit-medical-systems-inc-loss-submission-form/?id=4793&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 569702

Natural Dogs’ Salmon Oil from Noted Brand Now in Leak-Proof Bottle

Natural dogs’ salmon oil from Natural Dog Treats is now available in leak-proof convenience bottles that have dosing pumps for easy administration and to prevent spills during storage.

Vilnius, Vilnius mun., Lithuania – December 9, 2019

Natural Dog Treats, a manufacturer of organic products for pets, is excited to announce that its natural dogs salmon oil, available on Amazon, comes in leak-proof bottles with a dosage pump to ensure safe storage and ease of use. According to the brand, the fish oil supplement is made purely from salmon sourced from Norway.

A spokesperson for Natural Dog Treats says, “With the dosage pumps, you can always be sure that you are giving the proper amount for the size and breed your dog. Simply follow the instructions on the back of the bottle; there is a recommended dietary chart to guide users on how much to add to a dog’s food, depending on size, breed and health. We’ve also made sure that the bottles are leak-proof because no one wants their house to smell like fish if some of the contents were to spill.”

A happy Amazon buyer writes in his review, “It made my dog look healthy inside and out! His fur is super smooth now and less prone to tangles, plus it’s shiny too. I was having second thoughts about buying this at first, but after seeing its effects, my dog’s diet won’t ever not have this again.”

“Our supplement for dogs made from 100% natural salmon oil, a natural source of omega-3 and 6 fatty acids. The fish oil comes with vital nutrients and is recommended to use daily together with other dog food. Our liquid formula is perfect for any size dog and breed to keep their fur shiny, their nails strong, and ensure their overall health in the years to come,” the company spokesperson adds.

Anyone interested in finding out more information about Natural Dogs Treats’ products should visit their storefront on Amazon.

 

###

Facebook: https://www.facebook.com/NaturalDogTreatsShop

Instagram: https://www.instagram.com/natural_dog_treats/

Youtube: https://www.youtube.com/channel/UCFerVdNSY1-czJd-NfTtn3Q

About Us: Natural Dog Treats was founded with one main goal – to provide the best, single-ingredient pet treats on the market. Using only 100% natural ingredients, we offer a range of pet products focused on enabling our pets to enjoy life to the fullest.

Contact Info:
Name: Simas Zelvys
Email: Send Email
Organization: Ventus artis, MB
Address: J. Franko g., Vilnius, Vilnius mun., 08431, Lithuania
Phone: +37062806930
Website: https://www.naturaldogtreats.net

Release ID: 88938465

Diamond Jewelry Cleaner Delivers Professional Results at Home

BrightDiamonds, a producer of jewelry cleaning products, has released a 3-pack of its diamond jewelry cleaner. This innovative cleaning solution has been advertised as the safest and most effective way to clean jewelry at home.

Ramat Gan, Israel – December 9, 2019

BrightDiamonds is pleased to report that since the release of its popular diamond jewelry cleaner as a 3-pack, the customer response has been positive to date. The brand says that users have consistently expressed satisfaction with the product and would recommend it to others who need a fast and cost-effective way of cleaning their jewelry at home.

“Most jewelry cleaning solutions available for use at home contain harsh chemicals and require the use of cleaning brushes and polishing cloths, all things that can actually result in scratching or damaging of gemstones and precious metals,” said Alyssa Stern, the spokesperson for BrightDiamonds. “Our polishing powders are ammonia-free and require only a pot of boiling water, which eliminates the possibility of damaging jewelry or users potentially touching harsh chemicals. An excellent gold jewelry cleaning solution, our 3-pack can be safely used on all non-treated gemstones and metals, including gold and platinum.”

One very satisfied Amazon customer gave an outstanding review on the white gold cleaning powder: “I heard good things about BrightDiamonds’ Jewelry Cleaner, but when I used it for the first time, I was amazed. My jewelry looked brand new! My friends and family couldn’t believe it was my same engagement ring and wedding band. I highly recommend this to anyone who wants to see results!”

“The solution penetrates every tiny space and crevice of necklaces, bracelets, rings and earrings for a deep clean without the need of scrubbing, brushing, wiping or polishing for a completely hands-off approach with exceptional results. We are confident that users will not be disappointed since our formula has been thoroughly tested and will provide brilliant results in only 10 minutes,” Stern added.

Those interested in finding out more about BrightDiamonds’ 3-pack jewelry cleaner should visit the company’s official website or Amazon storefront.

 

###

About Us: Bright Diamonds Ltd was founded to deliver new innovative, advanced & safe product solutions for cleaning diamond, gold, platinum, silver and precious stone jewelry, as well as silverware cleaning

Contact Info:
Name: Aharon Cohen
Email: Send Email
Organization: BrightDiamonds
Address: 7 Aba Hilel Street, Ramat Gan, 5252204, Israel
Phone: 073-2793444
Website: https://www.b-diamonds.com

Release ID: 88938469

Exfoliating Face Wash with Glycolic Acid Highlighted as Beauty Treatment

À La Paix recently discussed the beauty benefits of its exfoliating face wash with glycolic acid. The product contains natural fruit acids and jojoba seeds that help smooth fine lines on the face, eliminate spots and control acne and more.

Georgetown, TX, USA – December 9, 2019

À La Paix has recently discussed the beauty benefits of using its exfoliating face wash with glycolic acid. According to the brand, the product contains jojoba beads and other vital ingredients such as salicylic acid, alpha hydroxy acid (AHA) and beta hydroxy acid (BHA) that effectively cleanse the skin, smoothing fine lines and wrinkles, reducing spots on the face and controlling acne.

“Not only does our wonderful 6.7-ounce gel exfoliating cleanser contain AHA and BHA, but it also has glycolic and salicylic acids along with many other enriched natural ingredients such as jojoba beads, lactic acid, grapefruit oil and many more,” said a senior spokesperson for the company. “Together, these ingredients offer a deep cleansing while nourishing, soothing, rejuvenating and hydrating your skin. It has an amazing citrus scent that is not overpowering. The robust ingredients are ideal for an effective beauty treatment.”

The brand says that the glycolic cleanser face cream is a natural exfoliant that is made solely from natural fruit acids that help boost the regeneration of skin cells while also hydrating the skin and refreshing its texture.

“This gentle facial cleansing scrub can reduce the appearance of age spots, dark spots, sunspots, and other forms of discoloration while helping those prone to acne reduce the frequency of breakouts. It restores skin to its smooth, youthful look by reversing the aging process and pore size,” the senior spokesperson added.

For optimal results, the cream should be used at least two times every day as it is ideal for all skin types ranging from normal, oily and dry or a combination of the latter, according to the company. Individuals with sensitive skin can use the glycolic face cleanser about two or three times a week and increase the frequency over time.

“This product leaves my face feeling really clean and smooth because of the exfoliating ingredients. It does an exceptional job of taking off makeup. Not all products do a really thorough job, but this product does. I can highly recommend it,” writes a satisfied buyer on Amazon.

Anyone interested in finding out more information about the exfoliating face wash with glycolic acid from À La Paix should visit the company’s official website or Amazon storefront.

###

Twitter: https://twitter.com/@Alapaixbeauty

Facebook: https://www.facebook.com/WeAreALaPaix/

About Us: À La Paix is a brand dedicated to enhance personal lifestyles through quality products and a commitment to provide the best customer service available.

Contact Info:
Name: Jody Comet
Email: Send Email
Organization: À La Paix
Address: , Georgetown, TX, 78628, USA
Phone: (775) 557-8628
Website: https://www.alapaix.com

Release ID: 88938467

Ultrasound Boot Camp Training All-Inclusive Course For Beginners Launched

Ultrasound equipment continuing education provider Conquest Imaging, an MXR Imaging Company has launched a 5-day ultrasound training course. The course helps Biomed professionals upgrade their skills with hands-on training on multiple machine platforms.

Stockton, United States – December 9, 2019 /PressCable/

Conquest Imaging announced the launch of an all-inclusive ultrasound boot camp training course for beginners. The 5-day course features hands-on training that qualifies participants to service ultrasound equipment.

More information about Conquest Imaging an MXR Imaging Company is available at https://conquestimaging.com

The ultrasound servicing course covers the basics of ultrasound repair, preventive maintenance, and the multi-vendor DICOM (Digital Imaging and Communications in Medicine) standard. The course is taught from a Biomed perspective. The training program includes advanced practical training on GE Logiq E9, Vivid E9, Philips iU22, and iE33 platforms.

The comprehensive ultrasound maintenance program for service technicians includes ACI pre-approved CEU(continuing education units) covering the latest in ultrasound technology. Course modules include practical multi-platform troubleshooting and problem-solving. Biomed ultrasound repair course participants receive interactive tablet instruction and in-person training from experienced instructors and practitioners.

The week-long all-inclusive ultrasound technician training prepares participants for Certified Biomedical Equipment Technician (CBET) re-certification. Ultrasound courses are available all year round and can be customized to organization-specific training needs and machine platforms.

For more information, visit https://www.youtube.com/watch?v=kSEKi3qd3FU

The ultrasound products & services company operates two state-of-the-art ultrasound service training centers in Stockton, CA, and Fishers, IN. Conquest Imaging offers Buy-One-Get-One (BOGO) discounts and special rates for veterans and bulk training reservations.

According to a spokesperson for the ultrasound repair training provider, “Our boot camp program is designed to help both new and experienced Biomed professionals develop a comprehensive knowledge of preventative maintenance skills which they master for various platforms and equipment.”

Conquest Imaging an MXR Imaging Company is an ultrasound technology company offering comprehensive ultrasound solutions to the healthcare industry. Founded in the year 2000, the company provides ultrasound servicing, products, refurbishment, training, and 24/7 support for all leading industry platforms. Conquest Imaging holds an ISO 9001:2015 certification.

For more information about continuing education courses for ultrasound maintenance, call 866-900-9404 or visit https://conquestimaging.com/education/registration/training-request-form

Contact Info:
Name: Jacqueline Guerra
Email: Send Email
Organization: Conquest Imaging – An MXR Imaging Company
Address: 1815 Industrial Drive Suite 100, Stockton, CA 95206, United States
Phone: +1-209-942-8654
Website: https://conquestimaging.com/

Source: PressCable

Release ID: 88938122

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Under Armour (UA, UAA) Investors with Significant Losses to Contact Its Attorneys, Reminds Investors of Application Deadline

SAN FRANCISCO, CA / ACCESSWIRE / December 9. 2019 / Hagens Berman urges Under Armour, Inc. (NYSE: UA, UAA) investors who have suffered losses in excess of $100,000 to submit their losses now to learn if they qualify to recover compensable damages. A securities fraud class action has been filed against the company and senior executives.

Class Period: Aug. 3, 2016 – Nov. 1, 2019

Lead Plaintiff Deadline: Jan. 6, 2020

Sign Up: www.hbsslaw.com/investor-fraud/UA

Contact An Attorney Now: UA@hbsslaw.com

844-916-0895

Under Armour (UA, UAA) Securities Class Action:

The complaint alleges that Defendants misled investors by engaging in fraudulent accounting.

According to the complaint, Under Armour improperly shifted sales from quarter to quarter to appear healthier, including to keep pace with its long-running year-over-year 20% net revenue growth. In addition, Defendants concealed the U.S. Department of Justice's and U.S. Securities and Exchange Commission's investigations of Under Armour's accounting.

On Nov. 3, 2019, The Wall Street Journal reported that the Department of Justice and the Securities and Exchange Commission were investigating Under Armour to determine whether the company "shifted sales from quarter to quarter to appear healthier." On this news, the price of Under Armour shares fell sharply.

On Nov. 14, 2019, The Wall Street Journal reported (1) former Under Armour executives "said they scrambled to meet aggressive sales targets, borrowing business from future quarters to mask slowing demand in 2016," (2) the company "frequently leaned on retailers to take products early and redirected goods intended for its factory stores to off-price chains to book sales in the final days of a quarter," and (3) Federal investigators "are examining emails that show Under Armour's founder and chief executive, Kevin Plank, knew about efforts to move revenue between quarters, according to a person familiar with the matter."

If you invested in Under Armour between Aug. 3, 2016 and Nov. 1, 2019 (the "Class Period") and suffered significant losses, you may qualify to be a lead plaintiff – one who selects and oversees the attorneys prosecuting the case. Contact Hagens Berman immediately for more information about the case and being a lead plaintiff.

"We're focused on recovering investors' substantial losses and holding Under Armour and its senior management accountable for their alleged accounting fraud," said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you purchased shares of Under Armour and suffered significant losses, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Under Armour should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email UA@hbsslaw.com.

About Hagens Berman

Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

CONTACT:

Reed Kathrein, 844-916-0895

SOURCE: Hagens Berman

ReleaseID: 569637

CLASS ACTION UPDATE for IRBT, TWTR and FCAU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / December 9, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

iRobot Corporation (NASDAQ:IRBT)

IRBT Lawsuit on behalf of: investors who purchased November 21, 2016 – October 22, 2019
Lead Plaintiff Deadline: December 23, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/irobot-corporation-loss-form?prid=4792&wire=1

The filed complaint alleges that defendants misrepresented the reason for iRobot's acquisitions of Tokyo-based Sales on Demand Corporation and privately-held Robopolis SAS, which was to control the Company's largest distributors so that defendants could inflate sales and revenue figures by stuffing the channel. Defendants further misled investors by repeatedly telling them throughout the Class Period that the Company was seeing continued double-digit revenue growth, and by attributing the growth to increased demand for the Roomba vacuums, when in reality defendants were engaging in channel-stuffing to artificially boost sales. Defendants also misstated that the Company's channel inventory levels had not changed and would not change dramatically from quarter to quarter or year over year, when in fact iRobot was deliberately stuffing the channel in order to claim false revenue growth.

Twitter, Inc. (NYSE:TWTR)

TWTR Lawsuit on behalf of: investors who purchased August 6, 2019 – October 23, 2019
Lead Plaintiff Deadline: December 30, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/twitter-inc-loss-form?prid=4792&wire=1

The filed complaint alleges that defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated Twitter's common share price and operated as a fraud or deceit on purchasers of Twitter common stock by misrepresenting the Company's operating condition and future business prospects. The scheme was perpetrated by making positive statements about Twitter's business while defendants knew, or disregarded with deliberate recklessness, certain adverse facts. When defendants' prior misrepresentations were disclosed and became apparent to the market, the price of Twitter's common stock fell precipitously.

Fiat Chrysler Automobiles N.V. (NYSE:FCAU)

FCAU Lawsuit on behalf of: investors who purchased February 26, 2016 – November 20, 2019
Lead Plaintiff Deadline: January 31, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/fiat-chrysler-automobiles-n-v-loss-form?prid=4792&wire=1

According to the filed complaint, during the class period, Fiat Chrysler Automobiles N.V. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company employed a bribery scheme to obtain favorable terms in its collective bargaining agreement with United Automobile, Aerospace and Agricultural Implement Workers of America; (2) high-ranking Fiat officials were aware of and authorized the scheme; and (3) as a result, Defendants' statements about Fiat's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 569687

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Merit Medical Systems Inc. (MMSI) Investors with Significant Losses to Contact Its Attorneys, Securities Fraud Lawsuit Filed

SAN FRANCISCO, CA / ACCESSWIRE / December 9, 2019 / Hagens Berman urges Merit Medical Systems, Inc. (NASDAQ:MMSI) investors who have suffered losses in excess of $50,000 to submit their losses now to learn if they qualify to recover compensable damages. A securities fraud class action has been filed against the company and senior executives.

Class Period: Feb. 26, 2019 – Oct. 30, 2019
Lead Plaintiff Deadline: Feb. 3, 2020
Sign Up: www.hbsslaw.com/investor-fraud/MMSI
Contact An Attorney Now: MMSI@hbsslaw.com
844-916-0895

Merit Medical Systems (MMSI) Securities Class Action:

The complaint alleges that during the Class Period, Defendants misrepresented and concealed that the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule. The Company also provided false financial guidance for fiscal 2019 and 2020, according to the complaint.

The market began to learn the truth on July 25, 2019, when Merit announced disappointing Q2 2019 financial results and reduced FY 2019 revenue and earnings guidance. In response, the price of Merit shares plummeted $13.84, down 25% and wiping out over $750 million of the Company's market capitalization.

Then, about 3 months later, on October 30, 2019, Merit announced disappointing Q3 2019 financial results, reduced FY 2019 guidance for the second time in 3 months, and withdrew 2020 guidance in its entirety.

In response, the price of Merit shares declined 33%, wiping out over $530 million of the Company's market capitalization.

"We're focused on investors' losses and proving Merit lied about the successful onboarding of Cianna and Vascular Insights," said Reed Kathrein, the Hagens Berman partner leading the investigation.

Whistleblowers: Persons with non-public information regarding Merit should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email MMSI@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:

Reed Kathrein, 510-725-3000

SOURCE: Hagens Berman Sobol Shapiro LLP

ReleaseID: 569632